Twitter | Search | |
@LDawsonMD
Radiation oncologist. Princess Margaret Cancer Centre. Liver cancer specialist. Tweets are my own.
141
Tweets
168
Following
601
Followers
Tweets
@LDawsonMD retweeted
Jan Marie Eberth Dec 9
Now look at this... this is what happened in Delaware when they made screening and treatment fully accessible to all patients regardless of insurance.
Reply Retweet Like
@LDawsonMD 20h
Reply Retweet Like
@LDawsonMD retweeted
Vinay Prasad 2.0 Dec 5
Just OUT! In Chris Booth and I discuss the implications of the modern phenomenon of many me-too cancer drugs, tested in redundant and duplicative portfolios How should we interpret individual successes? [THREAD]
Reply Retweet Like
@LDawsonMD retweeted
Sandra Turner Dec 5
Is the question ARE offered or SHOULD be offered? Sadly very different answers. 😞
Reply Retweet Like
@LDawsonMD retweeted
Jenna Kahn, MD Dec 3
Single-Fraction vs Multifraction Radiotherapy and Ambulatory Status in Patients With Spinal Canal Compression
Reply Retweet Like
@LDawsonMD Dec 3
I enjoyed my visit. Loved the natural light at the bunkers!
Reply Retweet Like
@LDawsonMD Nov 28
Agree. fellows are outstanding.
Reply Retweet Like
@LDawsonMD retweeted
Julie McCrossin AM Nov 28
A glimpse of part the Peter MacCallum Cancer Centre “chill-out space”, created with support from Sony, for young people to go to during their cancer treatment. There is a music room & sleeping nooks & more.
Reply Retweet Like
@LDawsonMD retweeted
Valerie A. Lewis 25 Jun 18
My goal: hire and train people who are smarter than I am, so that their careers surpass my own in impact. They may start off more junior, but their slope is steeper! I can't wait to see the amazing things some of these amazing rising colleagues will do in their careers!
Reply Retweet Like
@LDawsonMD retweeted
gilberto lopes Nov 26
we can’t develop the human capital we need to fight cancer around the world with our current training models and investment
Reply Retweet Like
@LDawsonMD retweeted
Tatiana Prowell, MD Nov 25
By popular request, a link to our one-pager on pt- & colleague-respectful language to share w/ others, incl those outside . It is a start & will surely evolve as we do, but it lives online here at : . ❤️ to bookmark
Reply Retweet Like
@LDawsonMD retweeted
Vivek Subbiah, MD Nov 24
Replying to @myESMO
Patient reported outcomes Practice changing study.
Reply Retweet Like
@LDawsonMD retweeted
Vivek Subbiah, MD Nov 24
Replying to @myESMO
Atezolizumab + Bevacizumab HR 0.58, p = 0.0006 compared to sorafenib.
Reply Retweet Like
@LDawsonMD retweeted
Pierre Blanchard, MD Nov 23
Important results of atezolizumab-bevacizumab combo in unresectable . Certainly practice changing. Big question is the affordability of the treatment in LMIC where most cases happen. Cc
Reply Retweet Like
@LDawsonMD Nov 22
OS curve impressive for atezo-Bev in HCC
Reply Retweet Like
@LDawsonMD retweeted
BCLC GROUP Nov 22
Looking forward to the Atezo-Beva combination vs sorafenib in 1st line. Phase 3 results announced positive. The field is expecting.
Reply Retweet Like
@LDawsonMD Nov 22
Exciting news for . Looking forward to details
Reply Retweet Like
@LDawsonMD Nov 21
Well said! Terrific advice about
Reply Retweet Like
@LDawsonMD retweeted
Sandra Turner Nov 18
Proud of you ⁦⁩ “Bronwyn King named Melburnian of the Year” ⁩ ⁦
Reply Retweet Like
@LDawsonMD retweeted
Dr. Carri Glide-Hurst Nov 18
Take note and ! Who else strongly endorses conference puppy snuggles? 🐶 🐾 ❤️
Reply Retweet Like